RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. MRL Ventures Fund
M

MRL Ventures Fund portfolio

MRL Ventures Fund has 4 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 4.
Deals, last 12 months: 0.
Rounds led: 2 of 8.
Capital in their rounds: $558M.
Latest deal: Therini Bio · May 19, 2025.
About this page

It led 2 of the 8 rounds it joined. Its most recent investment on record is Therini Bio's $39M Series A round in May 2025, alongside Apollo Health Ventures, Eli Lilly, Dolby Family Ventures and 5 others. By category, its portfolio leans toward Health and bio (4) and Legal and compliance (1). It has co-invested with GV, ARCH Venture Partners and Blue Pool Capital, most often GV (3 rounds).

What MRL Ventures Fund invests in

MRL Ventures Fund recent investments

How MRL Ventures Fund invests

StageDealsCapital in rounds
Series B+ 4 50%$390M
Series A 3 38%$151M
Seed 1 13%$17M
YearDealsCapital in rounds
2017 1 13%$55M
2020 1 13%$65M
2021 3 38%$167M
2022 1 13%$175M
2024 1 13%$57M
2025 1 13%$39M

MRL Ventures Fund portfolio companies

CompanyRound with MRL Ventures FundTotal raisedLatest raise
TTherini Bio
Health and bio
Series A · $39M$56MMay 21, 2026
Series A
AATB Therapeutics
Health and bio
Series A · $57M · lead$57MDec 2, 2024
Series A
LLifeMine Therapeutics
Health and bio
Series B+ · $175M$543MAug 6, 2026
Series B+
HHotSpot Therapeutics
Legal and compliance
Series B+ · $100M$210MNov 29, 2021
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 8 rounds on Recent Funding that name MRL Ventures Fund. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists MRL Ventures Fund, which is a subset of its real portfolio. API: /api/v1/investors/mrl-ventures-fund (get a free API key). More: the most active VC firms and new venture capital funds.